Search Count: 28
 |
Crystal Structure Of Apobec3G Catalytic Domain Complex With Ssdna Containing 2'-Deoxy Zebularine.
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2022-12-14 Classification: HYDROLASE/DNA Ligands: ZN |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UMN |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UNW |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UO5 |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOH |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, EDO, UOE |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOW |
 |
Organism: Streptococcus pneumoniae serotype 2 (strain d39 / nctc 7466), Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2021-08-25 Classification: TRANSPORT PROTEIN/IMMUNE SYSTEM |
 |
Organism: Streptococcus pneumoniae serotype 2 (strain d39 / nctc 7466)
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2021-08-25 Classification: TRANSPORT PROTEIN Ligands: PO4, MA4 |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQT |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQW |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERZ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EU2 |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQZ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESQ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ER8 |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERW |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERK |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESK |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESW |